Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study

BACKGROUND: Tumor immune cells influence the efficacy of immune-checkpoint inhibitors (ICIs) and many efforts aim at identifying features of tumor immune microenvironment able to predict benefit from ICIs in proficient mismatch repair (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Moretto, Roberto, Rossini, Daniele, Catteau, Aurélie, Antoniotti, Carlotta, Giordano, Mirella, Boccaccino, Alessandra, Ugolini, Clara, Proietti, Agnese, Conca, Veronica, Kassambara, Alboukadel, Pietrantonio, Filippo, Salvatore, Lisa, Lonardi, Sara, Tamberi, Stefano, Tamburini, Emiliano, Poma, Anello Marcello, Fieschi, Jacques, Fontanini, Gabriella, Masi, Gianluca, Galon, Jérôme, Cremolini, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124320/
https://www.ncbi.nlm.nih.gov/pubmed/37085190
http://dx.doi.org/10.1136/jitc-2022-006633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124320/
https://www.ncbi.nlm.nih.gov/pubmed/37085190
http://dx.doi.org/10.1136/jitc-2022-006633

Ejemplares similares